Alpa Laboratories
Alpa Laboratories Performance
Day Range
- Low 71.85
- High 74.9
52 Week Range
- Low 49
- High 85.9
- Open Price71.85
- Previous Close72.25
- Volume52831
Start SIP in Alpa Laboratories
Start SIPAlpa Laboratories Investment Rating
-
Master Rating:
-
Alpa Laboratories has an operating revenue of Rs. 95.45 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 17% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 11% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 25 | 29 | 27 | 14 | 22 | 26 |
| Operating Expenses Qtr Cr | 27 | 20 | 25 | 19 | 21 | 27 |
| Operating Profit Qtr Cr | -1 | 9 | 3 | -6 | 1 | -1 |
| Depreciation Qtr Cr | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 3 | 0 | 0 | 0 | 5 |
| Net Profit Qtr Cr | 3 | 5 | 5 | 0 | 3 | -4 |
Alpa Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹75.53
- 50 Day
- ₹73.65
- 100 Day
- ₹70.2
- 200 Day
- ₹66.87
- 20 Day
- ₹76.86
- 50 Day
- ₹74.08
- 100 Day
- ₹68.65
- 200 Day
- ₹64.65
Alpa Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹73.44 |
| Second Resistance | ₹74.62 |
| Third Resistance | ₹75.44 |
| RSI | 41.79 |
| MFI | 44.37 |
| MACD Single Line | 0.8 |
| MACD | -0.08 |
| Support | |
|---|---|
| First Resistance | ₹71.44 |
| Second Resistance | ₹70.62 |
| Third Resistance | ₹69.44 |
Alpa Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 45,647 | 2,721,931 | 59.63 |
| Week | 58,795 | 3,612,968 | 61.45 |
| 1 Month | 222,871 | 10,922,912 | 49.01 |
| 6 Month | 125,545 | 6,737,991 | 53.67 |
Alpa Laboratories Result Highlights
Alpa Laboratories Synopsis
NSE-Medical-Generic Drugs
Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 92.44 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2023. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.| Market Cap | 154 |
| Sales | 95 |
| Shares in Float | 0.90 |
| No of funds | 1 |
| Yield |
| Book Value | 1.05 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 2 |
| Alpha | 0.09 |
| Beta | 0.68 |
Alpa Laboratories
| Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
|---|---|---|---|---|
| Promoters | 57.29% | 57.29% | 57.29% | 57.29% |
| Foreign Portfolio Investors | 0.14% | |||
| Financial Institutions/ Banks | 0.01% | 0.01% | ||
| Individual Investors | 37.79% | 38.1% | 37.88% | 37.72% |
| Others | 4.91% | 4.6% | 4.83% | 4.85% |
Alpa Laboratories Management
| Name | Designation |
|---|---|
| Mr. Mahendra Singh Chawla | Chairman |
| Mr. Paresh Chawla | Managing Director |
| Mr. Devendra Baheti | Independent Director |
| Mr. Sharad Chand Lunawat | Independent Director |
| Mr. Krishna Das Malani | Independent Director |
| Mrs. Jyoti Jain | Independent Director |
| Mr. Pravin Shah | Director |
Alpa Laboratories Forecast
Price Estimates
Alpa Laboratories Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-08-14 | Quarterly Results | |
| 2023-05-29 | Audited Results | |
| 2023-02-14 | Quarterly Results | |
| 2022-11-14 | Quarterly Results | |
| 2022-08-13 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Adani Ports
- 829
- 1.3
- Tech Mahindra
- 1285
- 0.9
- Dr Reddys Labs
- 5655
- 0.7
- B P C L
- 355
- 0.6
- Bharti Airtel
- 916
- 0.6
- Company Name
- CMP
- Chg(%)
Alpa Laboratories FAQs
What is Share Price of Alpa Laboratories ?
Alpa Laboratories share price is ₹73 As on 21 September, 2023 | 14:37
What is the Market Cap of Alpa Laboratories ?
The Market Cap of Alpa Laboratories is ₹153.6 Cr As on 21 September, 2023 | 14:37
What is the P/E ratio of Alpa Laboratories ?
The P/E ratio of Alpa Laboratories is 11.8 As on 21 September, 2023 | 14:37
What is the PB ratio of Alpa Laboratories ?
The PB ratio of Alpa Laboratories is 1.1 As on 21 September, 2023 | 14:37